Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
National Institute for Health and Care Research · Imperial College London · +3 more institutions
Abstract
To explore and describe the current literature surrounding bacterial/fungal coinfection in patients with coronavirus infection.
MEDLINE, EMBASE, and Web of Science were searched using broad-based search criteria relating to coronavirus and bacterial coinfection. Articles presenting clinical data for patients with coronavirus infection (defined as SARS-1, MERS, SARS-CoV-2, and other coronavirus) and bacterial/fungal coinfection reported in English, Mandarin, or Italian were included. Data describing bacterial/fungal coinfections, treatments, and outcomes were extracted. Secondary analysis of studies reporting antimicrobial prescribing in SARS-CoV-2 even in absence of coinfection was performed.
Citation impact
- FWCI
- 164.04
- Percentile
- 100%
- References
- 57
Authors
9- TMTimothy M. RawsonCorresponding
National Institute for Health and Care Research, Imperial College London
- LMLuke Moore
Imperial College Healthcare NHS Trust, Chelsea and Westminster Hospital NHS Foundation Trust, Hammersmith Hospital, National Institute for Health and Care Research, Imperial College London
- NZNina Zhu
National Institute for Health and Care Research, Imperial College London
- NRNishanthy Ranganathan
Imperial College Healthcare NHS Trust, Hammersmith Hospital, Imperial College London
- KSKeira Skolimowska
Imperial College Healthcare NHS Trust, Hammersmith Hospital, Imperial College London
Topics & keywords
- Coinfection
- Medicine
- Antimicrobial
- Antimicrobial stewardship
- Coronavirus
- Intensive care medicine
- Microbiology
- Immunology
- Good health and well-being